Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

182
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
182
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

73
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
73
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

519
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
519
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

135
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
135
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

140
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
140
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

136
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
136

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysing Antibodies Against Respiratory Viruses in Breast Milk: A Pilot Study.

Viruses·2026
Same author

Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology.

Disease models & mechanisms·2026
Same author

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Orphanet journal of rare diseases·2026
Same author

Charting the circulating proteome in ME/CFS using cross-system profiling to uncover mechanistic insights.

Cell reports. Medicine·2026
Same author

SARS-CoV-2 T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trial.

Vaccine·2026
Same author

Serum proteome analysis detects early molecular signatures of disease progression in IgA nephropathy.

Clinical kidney journal·2026

Related Experiment Video

Updated: Oct 4, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K

Cardiovascular changes in young renal failure patients.

Camilla Tøndel1, Hans-Peter Marti2

  • 1Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.

Clinical Kidney Journal
|February 11, 2022
PubMed
Summary

Young patients with severe kidney disease show significant cardiovascular changes. Early detection and intervention are crucial for managing long-term health in pediatric renal failure survivors.

Keywords:
cardiorenal diseasecardiovascular diseasechildchronic kidney diseasedialysisyoung adults

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.1K
Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

105

Related Experiment Videos

Last Updated: Oct 4, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.1K
Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

105

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Medicine
  • Renal Failure Research

Background:

  • Advances in medical care enable more young patients with severe kidney disease and congenital anomalies of the kidney and urinary tract to survive into adulthood.
  • This demographic shift necessitates a focus on the long-term health implications of early-life kidney dysfunction, particularly cardiovascular effects.

Discussion:

  • A study by Lalayiannis et al. highlights significant structural and functional cardiovascular changes in young kidney failure patients (GFR <30 mL/min/1.73 m²).
  • Among 100 patients aged 5–30 years, 84 exhibited signs of cardiovascular disease, indicating a high prevalence of subclinical cardiovascular issues.

Key Insights:

  • Subclinical cardiovascular disease is prevalent in young patients with chronic kidney disease.
  • Early-onset renal failure significantly impacts cardiovascular health in pediatric and young adult populations.

Outlook:

  • There is a critical need for long-term follow-up data on cardiovascular consequences in early-life renal failure.
  • Future research should evaluate prophylactic and therapeutic strategies to improve the prognosis for these patients.